MétaCan
Menu
Back to cohort
Record W4220803013 · doi:10.21203/rs.3.rs-1427931/v1

Combination Treatment with Histone Deacetylase and Carbonic Anhydrase 9 Inhibitors Shows Therapeutic Potential in Experimental Diffuse Intrinsic Pontine Glioma

2022· preprint· en· W4220803013 on OpenAlexafffund
Naohide Fujita, Andrew Bondoc, Joji Ishida, Michael S. Taccone, Alexandra Riemenshneider, Amanda Luck, Dilakshan Srikant, Robert Siddaway, Akihide Kondo, Hajime Arai, Christian A. Smith, Paul C. McDonald, Cynthia Hawkins, Shoukat Dedhar, James T. Rutka

Bibliographic record

VenueResearch Square · 2022
Typepreprint
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicHistone Deacetylase Inhibitors Research
Canadian institutionsHospital for Sick Children
FundersCanadian Institutes of Health ResearchCuring Kids CancerCure Starts Now Foundation
KeywordsPanobinostatVorinostatHistone deacetylaseCancer researchCombination therapyGliomaCell cycleHistone deacetylase inhibitorCell growthHistoneCarbonic anhydraseChemistryPopulationBiologyApoptosisPharmacologyBiochemistryMedicineEnzyme

Abstract

fetched live from OpenAlex

Abstract Purpose: Despite extensive research, an effective and safe treatment for diffuse intrinsic pontine glioma (DIPG) has not been established. In this study, we investigate the therapeutic potential of combination therapy with histone deacetylase (HDAC) and carbonic anhydrase 9 (CA9) inhibitors against DIPG.Methods: We used RNA sequencing data from DIPG patient samples to evaluate the expression of the carbonic anhydrase family and the activity of the hypoxia signaling pathway. Next, we performed a synergy screen using CA9 inhibitor SLC-0111 and the HDAC inhibitors panobinostat, vorinostat, entinostat, and pyroxamide. We selected the SLC-0111/HDACi combination showing the highest synergy, and its effects on cell proliferation, invasion, and migration were evaluated. We also measured changes in histone acetylation, apoptosis, cell cycle, and intracellular pH.Results: CA9 was significantly upregulated in human DIPG samples. Furthermore, pathways downstream of CA9 were found to be activated when compared to normal brain tissue. The synergy screen revealed that the combination of SLC-0111 and pyroxamide was most effective at inhibiting DIPG cell proliferation. Furthermore, this combination reduced cell migration and invasion potential while enhancing histone acetylation with subsequent reduction of cell population in S Phase. Finally, the SLC-0111 and pyroxamide combination showed greater reduction of intracellular pH as compared to each agent alone.Conclusion: Our in vitro data suggest that the combination of SLC-0111 and pyroxamide shows promise in the treatment of experimental DIPG. Based on these findings, further investigation of this combination therapy in preclinical models is warranted.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.022
GPT teacher head0.350
Teacher spread0.328 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes2
Has abstractyes

Explore more

Same venueResearch SquareSame topicHistone Deacetylase Inhibitors ResearchFrench-language works237,207